Clinical Trial Update: Exploration of Predictive Markers of Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer

View source ↗

Summary

A clinical trial (NCT05965557) sponsored by Geneplus-Beijing Co. Ltd is investigating predictive biomarkers for the effectiveness of neoadjuvant immunotherapy i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Geneplus-Beijing Co. Ltd. | Conditions: Lung Cancer | Status: RECRUITING